Clarke Inc
Clarke Inc. is a private equity and venture capital firm specializing in investments in middle market, turnaround, PIPEs, bridge financing, recapitalization, and buyout companies. It invests in undervalued or underperforming businesses with hard assets. It invests in companies, securities or other assets such as real estate, which can be public or private entities. The firm primarily invests equi… Read more
Clarke Inc (CLKFF) - Total Liabilities
Latest total liabilities as of September 2025: $331.58 Million USD
Based on the latest financial reports, Clarke Inc (CLKFF) has total liabilities worth $331.58 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Clarke Inc - Total Liabilities Trend (1998–2024)
This chart illustrates how Clarke Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Clarke Inc Competitors by Total Liabilities
The table below lists competitors of Clarke Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Thai Nakarin Hospital Public Company Limited
BK:TNH
|
Thailand | ฿563.40 Million |
|
Formosa Oilseed Processing Co Ltd
TW:1225
|
Taiwan | NT$3.81 Billion |
|
Winchester Bancorp, Inc. Common Stock
NASDAQ:WSBK
|
USA | $897.72 Million |
|
Advanced Emissions Solutions Inc
F:OXQ1
|
Germany | €60.79 Million |
|
PCC Rokita SA
WAR:PCR
|
Poland | zł963.17 Million |
|
Helios Fairfax Partners Corporation
PINK:FFXXF
|
USA | $22.53 Million |
|
QUALITAS SEMICONDUCTOR CO. LTD.
KQ:432720
|
Korea | ₩39.71 Billion |
|
G&E Herbal Biotechnology Co., Ltd.
TWO:4911
|
Taiwan | NT$66.45 Million |
Liability Composition Analysis (1998–2024)
This chart breaks down Clarke Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Clarke Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Clarke Inc (1998–2024)
The table below shows the annual total liabilities of Clarke Inc from 1998 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $239.44 Million | +45.61% |
| 2023-12-31 | $164.44 Million | -18.25% |
| 2022-12-31 | $201.15 Million | +14.28% |
| 2021-12-31 | $176.01 Million | +23.58% |
| 2020-12-31 | $142.42 Million | -6.06% |
| 2019-12-31 | $151.60 Million | +976.51% |
| 2018-12-31 | $14.08 Million | +230.59% |
| 2017-12-31 | $4.26 Million | -22.04% |
| 2016-12-31 | $5.46 Million | -32.90% |
| 2015-12-31 | $8.14 Million | -28.41% |
| 2014-12-31 | $11.37 Million | -92.09% |
| 2013-12-31 | $143.73 Million | +3.53% |
| 2012-12-31 | $138.83 Million | -9.02% |
| 2011-12-31 | $152.59 Million | +2.98% |
| 2010-12-31 | $148.18 Million | -14.23% |
| 2009-12-31 | $172.77 Million | -20.14% |
| 2008-12-31 | $216.35 Million | +6.66% |
| 2007-12-31 | $202.85 Million | -13.51% |
| 2006-12-31 | $234.53 Million | +115.08% |
| 2005-12-31 | $109.04 Million | +107.39% |
| 2004-12-31 | $52.58 Million | -17.46% |
| 2003-12-31 | $63.70 Million | +3.28% |
| 2002-12-31 | $61.67 Million | -3.01% |
| 2001-12-31 | $63.59 Million | -20.15% |
| 2000-12-31 | $79.63 Million | +14.25% |
| 1999-12-31 | $69.70 Million | +1.60% |
| 1998-12-31 | $68.60 Million | -- |